Whitepaper

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities. Today the Pharma industry has a lot of blue ocean opportunities that are yet to be explored when it comes to digital innovations.

Key Takeaways:

  • SGA has helped design these blue ocean strategies for the client, enabling them to switch from red ocean to blue ocean.
  • It is a patient-centric data-gathering process designed for a specific disease. 
  • Through the process, we assisted the client in gathering significant insights from data streams, thus making it easier to present matches between patients with specific needs and identify the best therapies.

To know more...



Related Topics

Decoding ISSB- ESG Whitepaper

White Papers

Decoding ISSB

The International Sustainability Standards Board, or ISSB, aims to integrate various existing sustainability frameworks to create a unified set of standards...

ATxSG Broadcast Asia

White Papers

ATxSG BroadcastAsia 2024: Key Trends

ATxSG is one of the leading technology conferences in Asia-Pacific with two primary focus avenues, i.e., BroadcastAsia and CommunicAsia, with close to...

We bring comprehensive data driven insights to everyone, everywhere